Cargando…

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?

Chronic kidney disease (CKD) is a well-known risk factor for postoperative complications in several surgical fields. However, although prevalent among diabetic candidates for vitrectomy, the effect of CKD on vitrectomy outcomes remains unclear. This study aimed at clarifying the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kameda, Yusuke, Saeki, Tadashiro, Hanai, Ko, Suzuki, Yuta, Uchigata, Yasuko, Babazono, Tetsuya, Kitano, Shigehiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621452/ https://www.ncbi.nlm.nih.gov/pubmed/34830589 http://dx.doi.org/10.3390/jcm10225309

Ejemplares similares

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Renal function after intravitreal administration of vascular endothelial growth factor inhibitors in patients with diabetes and chronic kidney disease
por: Kameda, Yusuke, et al.
Publicado: (2018)

Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus
por: Toya, Kiwako, et al.
Publicado: (2013)

Giant retinal pigment epithelial tear associated with fluid overload due to end-stage diabetic kidney disease
por: Kameda, Yusuke, et al.
Publicado: (2016)

Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
por: Otani, Toshika, et al.
Publicado: (2019)

Obesity as an effect modifier of the association between leptin and diabetic kidney disease
por: Hanai, Ko, et al.
Publicado: (2013)

Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy
por: Al-khersan, Hasenin, et al.
Publicado: (2020)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Association of Serum Leptin Levels With Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
por: Hanai, Ko, et al.
Publicado: (2011)

Prediction of Retinopathy at 20 Years After Onset in Younger-Onset Type 1 Diabetes Using Mean Metabolic Memory-Free HbA(1c) Values: The importance of using HbA(1c) data of total, not partial, diabetes duration
por: Hirose, Akira, et al.
Publicado: (2013)

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome
por: Tajiri, Kensuke, et al.
Publicado: (2015)

Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy
por: Schreur, Vivian, et al.
Publicado: (2020)

Vitrectomy for Proliferative Diabetic Retinopathy in a Patient with Heparin-Induced Thrombocytopenia
por: Fujii, Tomoko, et al.
Publicado: (2016)

Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study
por: Takayama, Kei, et al.
Publicado: (2019)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2023)

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017)

Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients
por: Zhao, Meng, et al.
Publicado: (2023)

Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device
por: Fukuo, Motonobu, et al.
Publicado: (2016)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Incidence of and Risk Factors for Postoperative Hyphema After 23-Gauge Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
por: Nie, Yu-Hong, et al.
Publicado: (2021)

Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients
por: Gershoni, Assaf, et al.
Publicado: (2022)

Arterial Stiffness Is Associated With Incident Albuminuria and Decreased Glomerular Filtration Rate in Type 2 Diabetic Patients
por: Bouchi, Ryotaro, et al.
Publicado: (2011)

Evaluation of twenty-seven-gauge vitrectomy for complex proliferative diabetic retinopathy
por: Verma, Saurabh, et al.
Publicado: (2023)

Vitrectomy surgery of diabetic retinopathy complications
por: Constantin, Brănişteanu Daniel, et al.
Publicado: (2016)

Two Cases of Proliferative Diabetic Retinopathy with Marked Sheathing of the Retinal Arteries following Vitrectomy
por: Nishikawa, Yuko, et al.
Publicado: (2017)

Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET)
por: Takasaki, Keiko, et al.
Publicado: (2016)

Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti‐glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme‐linked immunosorbent assay
por: Takagi, Satoshi, et al.
Publicado: (2019)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
por: Tsubota, Kinya, et al.
Publicado: (2019)

Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy
por: Kamura, Yumi, et al.
Publicado: (2013)

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
por: Sakamoto, Masashi, et al.
Publicado: (2018)

Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
por: Liao, Mengyu, et al.
Publicado: (2020)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023)

27‑Gauge vitrectomy vs. 25‑gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept
por: Xiang, Wu, et al.
Publicado: (2023)

Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy
por: Yoshida, Shigeo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_shu5n16eokbov3o7eg3tm3lm0k